Paul E Dicorleto - Director, Cleveland Biolabs Inc
As of June 21, 2013
What is Paul E Dicorleto's Net Worth?
The current estimated net worth of Cleveland Biolabs Inc's Director, Paul E Dicorleto, is estimated to be about $0 . Paul E Dicorleto owns about 31,866 units of Cleveland Biolabs Inc common stock. In the last 6 years at Cleveland Biolabs Inc, Paul E Dicorleto has sold an estimated value of $0 worth.
What is Paul E Dicorleto's Past Insider Trading?
Paul E Dicorleto's largest purchase order was 6,210 units , worth over $10K on May 23, 2013. In total, Paul E Dicorleto has made about 8 transactions over 6 years of their time at Cleveland Biolabs Inc. Paul E Dicorleto usually trades in June, with the busiest year in 2013.
Paul E DiCorleto
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Paul E Dicorleto's' Mailing Address?
- Mailing address is 11000 Cedar Ave. Suite 280 Cleveland OH 44106 OH
Cleveland Biolabs Inc Executive Compensation
Name |
Year
|
Salary
|
Other Compensation
|
Total
|
|---|---|---|---|---|
| Langdon L. Miller | 2019 | $73,725 | - | $77,625 |
| Langdon L. Miller | 2018 | $119,550 | - | $119,550 |
| Andrei Gudkov | 2019 | $66,138 | - | $66,138 |
| Andrei Gudkov | 2018 | $110,941 | - | $110,941 |
| Christopher Zosh | 2019 | $92,463 | $11,031 | $103,494 |
| Christopher Zosh | 2018 | $73,031 | $9,161 | $82,192 |
| Yakov Kogan | 2019 | $264,323 | $50,607 | $314,930 |
| Yakov Kogan | 2018 | $276,000 | $10,800 | $286,800 |
| No matching records found | ||||
Source: https://www.sec.gov/Archives/edgar/data/1318641/000143774920023024/cbli20201029_def14a.htm
What are Cleveland Biolabs Inc's Past Insider Trades?
Cleveland Biolabs Inc's most recent insider trade came on February 27, 2015 by Randy S Saluck who bought 1,891 units worth $6.47K . In the last 8 years, insiders at Cleveland Biolabs Inc have sold an estimated value of $1.16M and bought an estimated value of $275.69K worth of shares. Insider trading is most common in June, with the busiest year in 2010. The most active traders at the company are Yakov Kogan, Chief Executive Officer, Andrei Gudkov, Chief Scientific Officer, and Michael Fonstein, President .
Cytocom, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||